Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Drug Manufacturers - Major Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Offer is closed
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Dec 22, 2021 12:55pm
109 Views
Post# 34255018

RE:RE:RE:RE:Offer is closed

RE:RE:RE:RE:Offer is closed
colts123 wrote: Pretty sad when the market tells what they think of this POS. They were initially looking to raise $13m, then reduced to $6.1m now they have to settle for $2.1 million, with a burn rate of 1.5m per month. what will they do after January 2022 . 
  Question, if they were so confident for approval from Heath Canada why didn't they wait until after the approval to do the public offering . Even if they did get the Health Canada approval it would only increase 20cents/share at best (my opinion). I am betting we will see 2 cents/share . To think they were pumping this stock to $3, $5 $10 and $20 a share this summer
  

Jeez,  I hope not ! Maybe Reduvo can get them up to .35 at least if it gets approved.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities